InsidersTradesSigma
CTT PHARMACEUTICAL HOLDINGS, INC.: management transactions · United States · SEC (Form 4)
Browse the full insider trade history of CTT PHARMACEUTICAL HOLDINGS, INC., a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €4.3m. The latest transaction was disclosed on 7 October 2025 (Acquisition). Among the most active insiders: CTT PHARMACEUTICAL HOLDINGS, INC.. Every trade is accessible without an account.
42
Insider Decl.
0
Thresholds
€29,691
39 ops.
Buy Volume
·
0 ops.
Sell Volume
32Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 7 October 2025
Declarations42 total
6,815 shares@ US$0.060.5% of flowCTTHSEC:0001035422-25-000014:0
Ideal exit: 20 Jun 2026 (T+270)
750,000 shares@ US$0.0438.8% of flowCTTHSEC:0001035422-25-000013:0
44,085 shares@ US$0.0452.6% of flowCTTHSEC:0001035422-25-000013:1
Ideal exit: 29 Apr 2026 (T+270)
8,000 shares@ US$0.030.3% of flowShares AcquiredSEC:0001035422-25-000010:0
Ideal exit: 4 Apr 2026 (T+270)
9,984 shares@ US$0.0650.9% of flowCTTHSEC:0001035422-25-000005:0
Ideal exit: 4 Jan 2026 (T+270)
15,510 shares@ US$0.051.1% of flowCTTHSEC:0001035422-25-000004:0
Ideal exit: 26 Dec 2025 (T+270)
5,400 shares@ US$0.060.4% of flowCTTHSEC:0001035422-25-000003:0
Ideal exit: 6 Dec 2025 (T+270)
11,950 shares@ US$0.091.5% of flowCTTHSEC:0001035422-25-000002:0
Ideal exit: 2 Dec 2025 (T+270)
5,200 shares@ US$0.120.9% of flowCTTHSEC:0001035422-25-000001:0
Ideal exit: 2 Nov 2025 (T+270)
23,346 shares@ US$0.062.0% of flowCTTHSEC:0001035422-24-000026:0
Ideal exit: 22 Aug 2025 (T+270)
750 shares@ US$0.0550.1% of flowCTTHSEC:0001035422-24-000025:0
Ideal exit: 8 Jun 2025 (T+270)
1,100 shares@ US$0.0550.1% of flowCTTHSEC:0001035422-24-000024:0
Ideal exit: 8 Jun 2025 (T+270)
1,000 shares@ US$0.060.1% of flowCTTHSEC:0001035422-24-000023:0
Ideal exit: 30 Apr 2025 (T+270)
550 shares@ US$0.060.0% of flowCTTHSEC:0001035422-24-000022:0
Ideal exit: 24 May 2025 (T+270)
2,900 shares@ US$0.050.2% of flowCTTHSEC:0001035422-24-000021:0
Ideal exit: 16 May 2025 (T+270)
1,300 shares@ US$0.040.1% of flowCTTHSEC:0001035422-24-000020:0
Ideal exit: 9 May 2025 (T+270)
2,200 shares@ US$0.0420.1% of flowCTTHSEC:0001035422-24-000019:0
Ideal exit: 3 May 2025 (T+270)
1,000 shares@ US$0.0420.1% of flowCTTHSEC:0001035422-24-000018:0
Ideal exit: 2 May 2025 (T+270)
1,600 shares@ US$0.040.1% of flowCTTHSEC:0001035422-24-000017:0
Ideal exit: 28 Apr 2025 (T+270)
3,100 shares@ US$0.040.2% of flowCTTHSEC:0001035422-24-000016:0
Ideal exit: 22 Apr 2025 (T+270)
1,700 shares@ US$0.040.1% of flowCTTHSEC:0001035422-24-000015:0
Ideal exit: 20 Apr 2025 (T+270)
2,000 shares@ US$0.050.1% of flowCTTHSEC:0001035422-24-000014:0
Ideal exit: 14 Apr 2025 (T+270)
1,800 shares@ US$0.060.1% of flowCTTHSEC:0001035422-24-000013:0
Ideal exit: 12 Apr 2025 (T+270)
1,070 shares@ US$0.060.1% of flowCTTHSEC:0001035422-24-000012:0
Ideal exit: 7 Apr 2025 (T+270)
2,730 shares@ US$0.060.2% of flowCTTHSEC:0001035422-24-000011:0
Ideal exit: 7 Apr 2025 (T+270)
25 of 42 declarations